Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;17(1):61-69.
doi: 10.1002/alz.12173. Epub 2020 Sep 4.

APOE interacts with tau PET to influence memory independently of amyloid PET in older adults without dementia

Affiliations

APOE interacts with tau PET to influence memory independently of amyloid PET in older adults without dementia

Alexandra J Weigand et al. Alzheimers Dement. 2021 Jan.

Abstract

Introduction: Apolipoprotein E (APOE) interacts with Alzheimer's disease pathology to promote disease progression. We investigated the moderating effect of APOE on independent associations of amyloid and tau positron emission tomography (PET) with cognition.

Methods: For 297 nondemented older adults from the Alzheimer's Disease Neuroimaging Initiative, regression equations modeled associations between cognition and (1) cortical amyloid beta (Aβ) PET levels adjusting for tau and (2) medial temporal lobe (MTL) tau PET levels adjusting for Aβ, including interactions with APOE ε4-carrier status.

Results: Adjusting for tau PET, Aβ was not associated with cognition and did not interact with APOE. In contrast, adjusting for Aβ PET, MTL tau was associated with all cognitive domains. Further, there was a stronger moderating effect of APOE on MTL tau and memory associations in ε4-carriers, even among Aβ-negative individuals.

Discussion: Findings suggest that APOE may interact with tau independently of Aβ and that elevated MTL tau confers negative cognitive consequences in Aβ-negative ε4 carriers.

Keywords: amyloid; apolipoprotein E; cognition; memory; positron emission tomography; tau.

PubMed Disclaimer

References

REFERENCES

    1. Corders EH, Saunders EM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science. 1993;261(5123):921-923.
    1. Hersi M, Irvine B, Gupta P, Gomes J, Birkett N, Krewski D. Risk factors associated with the onset and progression of Alzheimer's disease: a systematic review of the evidence. Neurotoxicology. 2017;61:143-187.
    1. Kanekiyo T, Xu H, Bu G. ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?. Neuron. 2014;81(4):740-754.
    1. Zhao N, Liu CC, Qiao W, Bu G. Apolipoprotein E, receptors, and modulation of Alzheimer's disease. Biol Psychiatry. 2018;83(4):347-357.
    1. Lim YY, Mormino EC; Alzheimer's Disease Neuroimaging Initiative. APOEgenotype and early β-amyloid accumulation in older adults without dementia. Neurology. 2017;89(10):1028-1034.

Publication types

MeSH terms